Glenmark Life Sciences Limited (GLS.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 96.19B |
| Enterprise Value | 93.35B |
| P/E Ratio | 23.62 |
| PEG Ratio | 1.1 |
| Price/Sales Ratio | 5.5 |
| Price/Book Ratio | 4.27 |
| Enterprise/Revenue | 5.52 |
| Enterprise/EBITDA | 16.35 |
Fiscal Year
| Fiscal Year | March 31, 2024 |
| Most Recent Quarter | September 30, 2024 |
Profitability
| Profit Margin | 0.23 |
| Operating Margin | 0.29 |
AD
Management Effectiveness
| Return On Assets | 0.15 |
| Return On Equity | 0.2 |
Income Statement
| Revenue | 22.83B |
| Revenue/Share | 211.05 |
| Gross Profit | 12.43B |
| EBITDA | 6.86B |
| Net Income | 4.71B |
| Diluted EPS | 38.38 |
Balance Sheet
| Total Cash | 5.3B |
| Total Cash/Share | 63.75 |
| Total Debt | 159.77M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 5.21 |
| Book Value Per Share | 271.48 |
Price History
| 52-Week Change | 23.62 |
| 52-Week High | 1,335.1 |
| 52-Week Low | 676.5 |
| Moving Average 50 Days | 1,046.58 |
| Moving Average 200 Days | 986.54 |
Statistics
| Average Volume | 125,749 |
| Shares Outstanding | 122.53M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 5 |
| Trailing Annual Dividend Yield | 0.43 |
| Payout Ratio | 0.1 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
